Podcast
AudioScholar Dermatology Weekly (India)
Hosted by AudioScholar · EN
Dermatology — a weekly podcast briefing of the most significant peer-reviewed dermatology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc. Indian-English narration.
13episodes
Episodes
Newest firstAll episodes
This Week in Dermatology — Aug 7, 2026
5d ago00:12:34Tap to summarizeWelcome to This Week in Dermatology. This week we're covering 10 notable papers spanning inflammatory disease classification and the economics of biologics, real-world outcomes in atopic dermatitis and psoriasis, and a cluster of practical papers on infection, hair loss, and melanocytic lesion surveillance. Let's dive in. We'll start with two papers in JAMA Dermatology that tackle very different…This week's papers:Pyoderma Gangrenosum Phenotype Classification — JAMA Dermatology 2026Approved Monoclonal Antibody Therapies for Hidradenitis Suppurativa — JAMA Dermatology 2026Treatment of tinea capitis in China: a multicenter prospective real-world study — Journal of the American Academy of Dermatology 2026Risk-adapted monitoring of melanocytic lesions with peripheral globules: a longitudinal cohort study on melanoma risk stratification — Journal of the American Academy of Dermatology 2026Systemic Comorbidities in Central Centrifugal Cicatricial Alopecia: A Systematic Review and Meta-analysis — Acta Dermato-Venereologica 2026Psoriatic patients with cancer: a multicentric real-life study comparing Risankizumab and Apremilast — Dermatology 2026Long-term effectiveness and safety of topical finasteride 0.25% monotherapy in male androgenetic alopecia: a 52-week real-world retrospective study — Clinical and Experimental Dermatology 2026Staphylococcal Scalded Skin Syndrome Often Does Not Require Empiric Coverage for Methicillin Resistance — Pediatric Dermatology 2026Early Clinical Response Predicts Treatment Persistence in Advanced Therapy-naive Atopic Dermatitis — Acta Dermato-Venereologica 2026Improvement of Depressive and Fatigue Symptoms under Dupilumab Therapy in Atopic Dermatitis Patients: Results from the TREATgermany Registry — Acta Dermato-Venereologica 2026Listen at AudioScholar
Transcribe →This Week in Dermatology — Jul 31, 2026
2w ago00:09:38Tap to summarizeWelcome to This Week in Dermatology. This week we are covering five notable papers spanning therapeutic advances and laboratory monitoring in alopecia areata, demographic variations in contact allergen sensitivities, multidimensional success metrics in hidradenitis suppurativa, and a critical update to the global naming system for biological therapies. Let's dive in. We begin with major clinical…This week's papers:Clinical Yield of Laboratory Monitoring During Ritlecitinib Treatment for Alopecia Areata: A Prospective Real-World Cohort Study — Journal of the American Academy of Dermatology 2026The Association of Race and Ethnicity with Patch Test Results: North American Contact Dermatitis Group Data, 2007-2020 — Journal of the American Academy of Dermatology 2026Long-term Efficacy and Safety of Upadacitinib in the Treatment of Alopecia Areata: A Retrospective Study — Journal of the American Academy of Dermatology 2026Measuring success in HS treatment from the physician's and the patient's perspective — Journal of the European Academy of Dermatology and Venereology 2026Decoding Biological Drug Names in Dermatology: The Post-2022 WHO Nomenclature Revision and Its Implications for Clinical Practice — Journal of the American Academy of Dermatology 2026Listen at AudioScholar
Transcribe →This Week in Dermatology — Jul 24, 2026
3w ago00:08:12Tap to summarizeWelcome to This Week in Dermatology. This week we're covering 10 notable papers spanning systemic therapeutics for inflammatory skin disease, diagnostic imaging innovations, and pediatric and supportive care. Let's dive in. [PAUSE] We begin with major advances in systemic therapies for inflammatory conditions and cutaneous oncology. In hidradenitis suppurativa, therapeutic options continue to ex…This week's papers:Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials. — Nature medicine 2026Clinical and Dermoscopic Triage of head and neck Macules: The Role of Reflectance Confocal Microscopy in a Prospective Study of 2006 Lesions. — Journal of the American Academy of Dermatology 2026Comparative effects of interventions for rosacea across phenotype-relevant outcomes: a systematic review and network meta-analysis. — Journal of the American Academy of Dermatology 2026Insulin Resistance is Not a Predictor of Response to Low-Dose Oral Metformin Therapy in Patients with CCCA: A Retrospective Review. — Journal of the American Academy of Dermatology 2026Magnified ultraviolet-induced fluorescence dermatoscopy for assessing mite viability in scabies. — Journal of the American Academy of Dermatology 2026Initial Psychometric Validation of the Caregiver Atopic Dermatitis Control Tool. — Clinical and experimental dermatology 2026High Level of Uncertainty in Assigning Causative Medications in Drug Reaction with Eosinophilia and Systemic Symptoms: A Retrospective Cohort Analysis. — Journal of the American Academy of Dermatology 2026A Comprehensive Review of the Current Systemic Medical Treatment Landscape for Vascular Malformations. — Pediatric dermatology 2026Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome. — The British journal of dermatology 2026Cutaneous leishmaniasis in patients in treatment with anti-TNF-α drugs. Study of 20 cases from a single institution. — Clinical and experimental dermatology 2026Listen at AudioScholar
Transcribe →This Week in Dermatology — Jul 17, 2026
4w ago00:13:04Tap to summarizeWelcome to This Week in Dermatology. This week we're covering 10 notable papers spanning systemic manifestations and novel therapeutics in psoriasis, real-world outcomes in hair restoration, and emerging safety and diagnostic data in inflammatory dermatoses. Let's dive in. [PAUSE] We begin with a deep look at psoriasis as a systemic disease and the potential for deep immunological resetting. In t…This week's papers:Efficacy and safety of inhibitory magnetic stimulation in the treatment of refractory erythema of rosacea: a prospective, randomized, controlled clinical trial. — Journal of the American Academy of Dermatology 2026Long-term Real-world Outcomes and Tolerability of Baricitinib in Alopecia Areata, Totalis, and Universalis: A Retrospective Single-center Cohort of 330 Patients with Trichoscopy Monitoring. — Journal of the American Academy of Dermatology 2026Increased Efficacy of Daytime Low-dose Oral Minoxidil Dosing for Androgenetic Alopecia: A Retrospective Study. — The British journal of dermatology 2026Cardiac structure and function in psoriasis: A cross-sectional analysis of the PSOCADIA study. — Journal of the European Academy of Dermatology and Venereology 2026Malignant transformation in mucosal lichen planus: A 10-year, single-center, descriptive cohort analysis. — Journal of the American Academy of Dermatology 2026Pemphigoid was not associated with increased risk of solid organ, hematologic, or nonmelanoma skin malignancies in a nationally representative matched cohort. — Clinical and experimental dermatology 2026Relapse prediction in rituximab-treated pemphigus patients: A prognostic model. — Journal of the European Academy of Dermatology and Venereology 2026Effect of semaglutide on hidradenitis suppurativa disease control and quality of life: A case series. — Journal of the European Academy of Dermatology and Venereology 2026Missed melanoma following skin lesion triage by an autonomous artificial intelligence system in a community setting. — Clinical and experimental dermatology 2026Long-term Remission of Severe Psoriasis Following CD19 CAR-T Cell Therapy for Follicular Lymphoma. — Clinical and experimental dermatology 2026Listen at AudioScholar
Transcribe →This Week in Dermatology — Jul 10, 2026
Jul 1100:09:39Tap to summarizeWelcome to This Week in Dermatology. This week we are covering ten notable papers spanning advanced management strategies for skin cancer, novel therapeutic insights in atopic dermatitis, and optimizing procedural and wound care outcomes. Let us dive in. We begin with atopic dermatitis, where new real-world data are helping clinicians optimize long-term maintenance and tailor therapies for specif…This week's papers:Compression therapies for venous leg ulcers: The VENous Ulcer Study 6 (VenUS 6), an open, multicentre, randomised clinical trial. — PLoS medicine 2026Real-world outcomes of 24-week abrocitinib tapering in moderate-to-severe atopic dermatitis: Feasibility and regimen comparison. — Journal of the American Academy of Dermatology 2026Recurrence of Basal Cell Carcinoma across Different Treatment Modalities: A Nationwide Study with 8 Years of Follow-up and Modelled Prediction. — Acta dermato-venereologica 2026Acneiform Eruption with Deucravacitinib: Systematic Review and Meta-Analysis. — Clinical and experimental dermatology 2026Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study. — Clinical and experimental dermatology 2026Clinical Predictors and a Novel Diagnostic Nomogram for Non-Bullous Pemphigoid: A 10-year Large-Scale Retrospective Case-Control Study. — Journal of the American Academy of Dermatology 2026Resource Use and Cost Comparison of Mohs Micrographic Surgery vs Traditional Surgery for High-risk Facial Basal Cell Carcinoma. — Acta dermato-venereologica 2026Compression Response During Ultrasound Aids Real-Time Differentiation of Pseudocysts and Tunnels in Hidradenitis Suppurativa. — Journal of the American Academy of Dermatology 2026Assessing Skin Cancer Risk in Systemic Sclerosis Patients with Organ Transplantation: A Cohort Study. — Journal of the American Academy of Dermatology 2026Near-Infrared Vascular Mapping to Guide Procedural Management of Superficial Cutaneous Vascular Lesions. — Journal of the American Academy of Dermatology 2026Listen at AudioScholar
Transcribe →This Week in Dermatology — Jul 3, 2026
Jul 400:07:03Tap to summarizeWelcome to This Week in Dermatology. This week we are covering seven notable papers spanning novel oral therapeutics for psoriasis, hair loss interventions, and complex dermatopathological entities. Let's dive in. [PAUSE] We begin with a major development in the management of moderate-to-severe plaque psoriasis. In the British Journal of Dermatology, researchers shared the one-year results from t…This week's papers:Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials. — The British journal of dermatology 2026Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study. — Journal of the American Academy of Dermatology 2026Safety of Biologic Therapy in Psoriasis Patients With Malignancy. — Journal of the American Academy of Dermatology 2026Comparative Alopecia Outcomes After Copper and Hormonal Intrauterine Device Placement: A TriNetX Database Retrospective Cohort Study. — Journal of the American Academy of Dermatology 2026Microneedling with adipose MSC exosomes versus monotherapy for androgenetic alopecia. — Journal of the European Academy of Dermatology and Venereology : JEADV 2026Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients. — The British journal of dermatology 2026Genomic Predictors of Perineural Invasion in Cutaneous Squamous Cell Carcinoma: Insights from an MD Anderson Cohort. — Journal of the American Academy of Dermatology 2026Listen at AudioScholar
Transcribe →This Week in Dermatology — Jun 27, 2026
Jun 2700:14:27Tap to summarizeWelcome to This Week in Dermatology. This week we're covering 9 notable papers spanning atopic dermatitis prevention and management, the systemic and behavioral burdens of chronic inflammatory skin diseases, and new insights into cutaneous biology and onco-dermatology. Let's dive in. We begin this week with a focus on atopic dermatitis, looking first at how early-life interventions might prevent…This week's papers:Proteomic analysis in hidradenitis suppurativa reveals systemic inflammation in all disease stages. — Journal of the European Academy of Dermatology and Venereology 2026Addiction in chronic inflammatory skin diseases: A systematic review of prevalence, impact and screening practices. — Journal of the European Academy of Dermatology and Venereology 2026Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris. — The Journal of Investigative Dermatology 2026The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue. — The Journal of Investigative Dermatology 2026Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled Trial. — The Journal of Investigative Dermatology 2026Randomised Controlled Feasibility Trial of an Intervention to Reduce Infant Bathing. — The British Journal of Dermatology 2026Male genital fixed drug eruption: a systematic review. — Clinical and Experimental Dermatology 2026Treatment Trajectories and Dose Optimization of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A Real-World Landmark Analysis. — Clinical and Experimental Dermatology 2026Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling. — Nature Medicine 2026Listen at AudioScholar
Transcribe →This Week in Dermatology — Jun 20, 2026
Jun 2000:10:25Tap to summarizeWelcome to This Week in Dermatology. This week we're covering nine notable papers spanning clinical screening strategies, advanced therapeutics for severe autoimmune and inflammatory conditions, and emerging prognostic models in patient care. Let's dive in. We begin with a focus on screening and clinical prediction, starting with a retrospective cohort study published in the Journal of the Americ…This week's papers:Outcomes of dermatologist-performed skin cancer screening in an academic setting: a retrospective cohort study. — Journal of the American Academy of Dermatology 2026Cobratide injection vs Pregabalin for Moderate-to-Severe Acute Herpes Zoster Neuralgia: A Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Exploratory Trial. — Journal of the American Academy of Dermatology 2026OX40 pathway inhibition and Kaposi sarcoma: An emerging safety signal in atopic dermatitis. — Journal of the European Academy of Dermatology and Venereology 2026Isotretinoin is not associated with elevated risk of pseudotumor cerebri: A Danish register-based cohort study. — Journal of the American Academy of Dermatology 2026Diagnosis and management of acyclovir-resistant herpes simplex virus for the dermatologist. — Journal of the American Academy of Dermatology 2026Autoimmune Disease in Central Centrifugal Cicatricial Alopecia: A Multi-Institutional Cross-Sectional Study. — Journal of the American Academy of Dermatology 2026Barbed Suture-Assisted High-Tension Cutaneous Closure: Brief Report of 493 Surgical Defects. — Journal of the American Academy of Dermatology 2026Daratumumab as a therapeutic option for rituximab-recalcitrant pemphigus. — The Journal of investigative dermatology 2026Prognostic prediction models for psoriatic arthritis in psoriasis: A systematic review. — Journal of the European Academy of Dermatology and Venereology 2026Listen at AudioScholar
Transcribe →This Week in Dermatology — Jun 13, 2026
Jun 1300:10:46Tap to summarizeWelcome to This Week in Dermatology. This week we're covering 7 notable papers spanning the rise and real-world performance of artificial intelligence, new approaches to prognostication in inflammatory disease and skin cancer, and the complex landscape of genodermatoses from molecular mechanisms to patient counseling. Let's dive in. We begin with a major theme this week: artificial intelligence.…This week's papers:General-purpose large language models outperform specialized clinical AI tools on medical benchmarks. — Nature medicine 2026An ITGB4 variant modifies the severity of ITGA3-associated interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa (ILNEB). — The Journal of investigative dermatology 2026Expanding histopathological assessment may provide limited prognostic value for metastatic cutaneous squamous cell carcinoma: insights from two nationwide nested case-control studies. — The British journal of dermatology 2026Effectiveness and safety of hematoporphyrin monomethyl ether-mediated photodynamic therapy versus pulsed dye laser for port-wine stain: a retrospective study. — Journal of the American Academy of Dermatology 2026Microdialysis-based metabolomic and proteomic profiling reveals signature variations for disease severity in psoriasis. — The Journal of investigative dermatology 2026Artificial intelligence in dermatology: Clinical promise and environmental impact. — The Journal of investigative dermatology 2026Patient Perspectives, Unmet Needs and Dilemmas in Reproductive Decision-making for Genodermatoses: A Qualitative Interview Study. — Acta dermato-venereologica 2026Listen at AudioScholar
Transcribe →This Week in Dermatology — Jun 6, 2026
Jun 600:06:18Tap to summarizeWelcome to This Week in Dermatology. This week we're covering several notable papers spanning the profound systemic and psychological burden of skin disease, and a critical look at cancer mortality in our high-risk transplant population. Let's dive in. First, three papers this week highlight that dermatologic conditions are far more than skin deep, carrying significant long-term physical and ment…This week's papers:Atopic dermatitis. — Nature reviews. Disease primers 2026Skin cancer mortality in Australian and New Zealand kidney transplant recipients: A population-based cohort study using linked health data, 1990-2019. — The British journal of dermatology 2026Suicidal ideation in patients with skin conditions: A multicentre European study. — Journal of the European Academy of Dermatology and Venereology : JEADV 2026Epidermal necrolysis sequelae: A cohort study on prevalence and risk factors. — Journal of the European Academy of Dermatology and Venereology : JEADV 2026Listen at AudioScholar
Transcribe →